Linagliptin Premix
Generic Name: linagliptin premix
Dosage form: POWDER. Active ingredients: LINAGLIPTIN (1 kg/kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Overview
Dosage form: POWDER. Active ingredients: LINAGLIPTIN (1 kg/kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Dosage
Available as powder.
Related Medications
Belantamab Mafodotin
belantamab mafodotin
11 DESCRIPTION Belantamab mafodotin‑blmf is a B‑cell maturation antigen (BCMA)‑directed antibody and microtubule inhibitor conjugate. Belantamab mafodotin‑blmf is an antibody conjugate composed of 3 components: 1) afucosylated, humanized immunoglobulin G1 monoclonal antibody covalently linked to 2) the microtubule inhibitor mcMMAF via 3) a protease‑resistant maleimidocaproyl linker.
Ibuprofen Mini
ibuprofen mini
Nonsteroidal Anti-inflammatory Drug [EPC]
Purpose Pain reliever/Fever reducer
Vaccinia Virus Modified Strain Ankara-bavarian Nordic Non-replicating Antigen
vaccinia virus modified strain ankara-bavarian nordic non-replicating antigen
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION. Route: SUBCUTANEOUS. Active ingredients: VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN (50000000 1/.5mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.